Company Overview

Headquartered in Bethlehem, PA, OraSure is a leader in the development, production, and distribution of point-of-care diagnostic and collection devices, and other technologies designed to detect or diagnose critical medical conditions. Our innovative products include rapid tests for COVID-19, HIV, HCV, syphilis, Ebola, and substance use. Bethlehem is home to our largest employee base and our state-of-the-art manufacturing facility.

OraSure is also the parent company of DNA Genotek, Inc., in Ottawa, Canada, where our team develops world-class sample collection solutions. Our portfolio of sample collection solutions includes innovation to stabilize multiple types of DNA and RNA samples for years at ambient temperature. The self-collection products for saliva, gut, oral, fecal, vaginal, and skin samples are designed to maximize reach and access to testing, enabling breakthroughs in genomics research, diagnostics laboratories, the pharmaceutical industry, animal genomics, and personal genomics. We also have a collection device for first-void urine samples that is used to detect certain urological cancers and sexually transmitted infections, currently available in some global geographies and for research use.

Number of Employees: 638 (as of 12/31/23)